Business · 10/06/2014
FDA Updates Postmarketing Safety Reporting Regulations for Human Drug and Biological Products
The FDA is requiring persons subject to mandatory reporting requirements to submit postmarketing safety reports in an electronic format, aiming to improve the Agency's systems for collecting and analyzing safety reports, and harmonize with international standards.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →